235
Participants
Start Date
June 30, 2011
Primary Completion Date
February 28, 2021
Study Completion Date
February 28, 2021
HepaSphere/QuadraSphere Microspheres
HepaSphere/QuadraSphere Microspheres loaded with doxorubicin
PVA, lipiodol, doxorubicin
Conventional TACE procedure using PVA, lipiodol and doxorubicin
University Hospitals K.U. Leuven (Dept of Hematology), Leuven
Mount Sinai Medical Center, New York
S. Croce e Carle Hospital, Cuneo
Albany Medical Center, Albany
VA Pittsburgh Healthcare System, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Albert Einstein Healthcare, Philadelphia
Georgetown University Hospital, Washington D.C.
MUSC Medical Center (Medical University of South Carolina), Charleston
Hospital Saint Andre, Bordeaux
Tampa General Hospital, Tampa
University of Alabama at Birmingham, Birmingham
Massachusetts General Hospital, Boston
Northwestern University, Chicago
Greater Arkansas Veterans Healthcare, Little Rock
UT Health and Science Center, San Antonio
Tuscon Medical Center, Tucson
VA Greater Los Angeles Healthcare System, Los Angeles
UCLA, Los Angeles
Palo Alto Veterans Institute for Research, Palo Alto
Stanford University, Stanford
Hospital Paul Brousse, Villejuif
Evgenidion University Hospital, Athens
Lead Sponsor
Merit Medical Systems, Inc.
INDUSTRY